A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy

NCT04159493 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Project terminated IND withdrawn

Conditions

Vaginal Atrophy

Interventions

DRUG: Estriol
DRUG: Placebo

Sponsor

Aspen USA Inc